Top Markets
Coin of the day
Nichi-Iko Pharmaceutical Co., Ltd. Nichi-Iko Pharmaceutical Co., Ltd.

Nichi-Iko Pharmaceutical Co., Ltd.

4541
Rangering i aksjer #8954
Nichi-Iko Pharmaceutical Co., Ltd. actively manufactures, distributes, imports,... Nichi-Iko Pharmaceutical Co., Ltd. actively manufactures, distributes, imports, and sells a wide variety of pharmaceutical products. Operating through its Sagent Group and Nichi-Iko Group segments, the company primarily focuses on the development and production of generic drugs. Its extensive product line encompasses antidiabetic, antacid, and antireflux agents, as well as beta-blockers, hypnotics, sedatives, angiotensin II antagonists (including combinations with diuretics), dyslipidemic agents, and calcium antagonists. These offerings target conditions affecting the circulatory, digestive, respiratory, central, and peripheral nervous systems, among others. Beyond pharmaceuticals, the company is also involved in packaging design and exports its products internationally. Established in 1947 as Nihon Iyakuhin Kogyo Co., Ltd., the firm officially became Nichi-Iko Pharmaceutical Co., Ltd. in 2005 and is headquartered in Toyama, Japan.
Aksjekurs
$0.22167204
Sist synkronisert: 2024-08-21
Markedsverdi
$1.13B
Endring (1 dag)
1.08%
Endring (1 år)
0.00%
Land
JP
Handel Nichi-Iko Pharmaceutical Co., Ltd. (4541)

Kategori

Inntekter for Nichi-Iko Pharmaceutical Co., Ltd. (4541)
Inntekter i 2026 TTM: 0
Ifølge Nichi-Iko Pharmaceutical Co., Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Nichi-Iko Pharmaceutical Co., Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter